Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma.
Contrera KJ, Ferrarotto R, Gunn B, Su SY, Kies MS, Glisson BS, Garden AS, Roberts D, Hanba C, Hoff CO, El-Naggar A, Williams MD, Raza SM, DeMonte F, Chen MM, Chambers MS, Hanna EY. Contrera KJ, et al. Among authors: ferrarotto r. Clin Cancer Res. 2024 Nov 12. doi: 10.1158/1078-0432.CCR-24-1416. Online ahead of print. Clin Cancer Res. 2024. PMID: 39531535
Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancer.
Bronk JK, Augustyn A, Mohamed ASR, David Fuller C, Garden AS, Moreno AC, Lee A, Morrison WH, Phan J, Reddy JP, Rosenthal DI, Spiotto MT, Frank SJ, Dadu R, Busaidy N, Zafereo M, Wang JR, Maniakas A, Ferrarotto R, Iyer PC, Cabanillas ME, Gunn GB. Bronk JK, et al. Among authors: ferrarotto r. Radiother Oncol. 2024 Nov 1;202:110602. doi: 10.1016/j.radonc.2024.110602. Online ahead of print. Radiother Oncol. 2024. PMID: 39489425 Free article.
Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial.
Cabanillas ME, Dadu R, Ferrarotto R, Gule-Monroe M, Liu S, Fellman B, Williams MD, Zafereo M, Wang JR, Lu C, Ning M, McKinley BA, Woodman SE, Duose D, Gunn GB, Busaidy NL; Rare Tumor Initiative Team. Cabanillas ME, et al. Among authors: ferrarotto r. JAMA Oncol. 2024 Oct 24:e244729. doi: 10.1001/jamaoncol.2024.4729. Online ahead of print. JAMA Oncol. 2024. PMID: 39446377 Free PMC article.
A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastoma.
Goodman CD, DeMonte F, Nguyen TP, Garden AS, Wang CH, Wang XA, Diao K, Lee A, Reddy J, Moreno A, Spiotto M, Fuller CD, Rosenthal D, Ferrarotto R, Raza SM, Su SY, Warner A, Hanna E, Phan J. Goodman CD, et al. Among authors: ferrarotto r. Head Neck. 2024 Jul 29. doi: 10.1002/hed.27887. Online ahead of print. Head Neck. 2024. PMID: 39073252
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement.
Hamidi S, Dadu R, Zafereo ME, Ferrarotto R, Wang JR, Maniakas A, Gunn GB, Lee A, Spiotto MT, Iyer PC, Sousa LG, Akhave NS, Ahmed S, Learned KO, Lu C, Lai SY, Williams M, Hosseini SM, Busaidy NL, Cabanillas ME. Hamidi S, et al. Among authors: ferrarotto r. JAMA Oncol. 2024 Sep 1;10(9):1264-1271. doi: 10.1001/jamaoncol.2024.2133. JAMA Oncol. 2024. PMID: 38990526
194 results